(TBCH) Turtle Beach - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US9004502061
Stock: Gaming Headset, Keyboard, Mouse, Microphone, Controller
Total Rating 23
Risk 65
Buy Signal -0.70
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 49.2% |
| Relative Tail Risk | -12.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.48 |
| Alpha | -55.61 |
| Character TTM | |
|---|---|
| Beta | 1.911 |
| Beta Downside | 2.573 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.77% |
| CAGR/Max DD | 0.23 |
Description: TBCH Turtle Beach December 29, 2025
Turtle Beach Corporation (NASDAQ:TBCH) designs, manufactures, and sells gaming audio and peripheral products-including headsets, microphones, keyboards, mice, and simulation accessories-under its own brand across North America, Europe, the Middle East, and the Asia-Pacific. The firm distributes primarily through retailers and wholesale partners and has operated since 1975 from its San Diego headquarters.
According to the company’s FY 2023 filing, revenue reached roughly $1.07 billion, up about 10 % year-over-year, with gross margins stabilizing near 38 % after a modest cost-of-goods-sold compression in 2022. Turtle Beach holds an estimated 30 % share of the dedicated gaming-headset market, a segment that tends to expand with new console cycles (e.g., PlayStation 5, Xbox Series X) and discretionary-spending trends in the broader consumer-electronics sector. Competitive pressure from Logitech, Razer, and console OEMs, as well as supply-chain volatility for semiconductor components, remain key risk factors.
If you want a data-driven deep-dive on TBCH’s valuation metrics and scenario analysis, ValueRay’s research platform offers a concise, model-ready overview.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 18.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 9.92 > 1.0 |
| NWC/Revenue: 19.24% < 20% (prev 12.49%; Δ 6.75% < -1%) |
| CFO/TA 0.13 > 3% & CFO 36.4m > Net Income 18.3m |
| Net Debt (78.2m) to EBITDA (41.5m): 1.88 < 3 |
| Current Ratio: 1.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (20.4m) vs 12m ago -5.09% < -2% |
| Gross Margin: 35.62% > 18% (prev 0.33%; Δ 3529 % > 0.5%) |
| Asset Turnover: 117.4% > 50% (prev 104.2%; Δ 13.26% > 0%) |
| Interest Coverage Ratio: 2.69 > 6 (EBITDA TTM 41.5m / Interest Expense TTM 10.8m) |
Altman Z'' 0.08
| A: 0.24 (Total Current Assets 178.4m - Total Current Liabilities 111.6m) / Total Assets 278.2m |
| B: -0.43 (Retained Earnings -120.0m / Total Assets 278.2m) |
| C: 0.10 (EBIT TTM 28.9m / Avg Total Assets 295.7m) |
| D: -0.71 (Book Value of Equity -118.5m / Total Liabilities 167.6m) |
| Altman-Z'' Score: 0.08 = B |
Beneish M -3.34
| DSRI: 0.75 (Receivables 56.8m/70.7m, Revenue 347.2m/326.2m) |
| GMI: 0.92 (GM 35.62% / 32.74%) |
| AQI: 0.97 (AQ_t 0.35 / AQ_t-1 0.35) |
| SGI: 1.06 (Revenue 347.2m / 326.2m) |
| TATA: -0.07 (NI 18.3m - CFO 36.4m) / TA 278.2m) |
| Beneish M-Score: -3.34 (Cap -4..+1) = AA |
What is the price of TBCH shares?
As of February 09, 2026, the stock is trading at USD 12.07 with a total of 156,814 shares traded.
Over the past week, the price has changed by -1.87%, over one month by -10.06%, over three months by -22.03% and over the past year by -32.08%.
Over the past week, the price has changed by -1.87%, over one month by -10.06%, over three months by -22.03% and over the past year by -32.08%.
Is TBCH a buy, sell or hold?
Turtle Beach has received a consensus analysts rating of 4.20.
Therefore, it is recommended to buy TBCH.
- StrongBuy: 2
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TBCH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19 | 57.4% |
| Analysts Target Price | 19 | 57.4% |
| ValueRay Target Price | 11.7 | -3.3% |
TBCH Fundamental Data Overview February 03, 2026
P/E Trailing = 13.5909
P/E Forward = 10.2775
P/S = 0.6823
P/B = 2.117
P/EG = 0.6425
Revenue TTM = 347.2m USD
EBIT TTM = 28.9m USD
EBITDA TTM = 41.5m USD
Long Term Debt = 48.4m USD (from longTermDebt, last quarter)
Short Term Debt = 42.1m USD (from shortTermDebt, last quarter)
Debt = 90.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 78.2m USD (from netDebt column, last quarter)
Enterprise Value = 315.1m USD (236.9m + Debt 90.5m - CCE 12.3m)
Interest Coverage Ratio = 2.69 (Ebit TTM 28.9m / Interest Expense TTM 10.8m)
EV/FCF = 9.34x (Enterprise Value 315.1m / FCF TTM 33.7m)
FCF Yield = 10.71% (FCF TTM 33.7m / Enterprise Value 315.1m)
FCF Margin = 9.72% (FCF TTM 33.7m / Revenue TTM 347.2m)
Net Margin = 5.26% (Net Income TTM 18.3m / Revenue TTM 347.2m)
Gross Margin = 35.62% ((Revenue TTM 347.2m - Cost of Revenue TTM 223.5m) / Revenue TTM)
Gross Margin QoQ = 37.36% (prev 28.64%)
Tobins Q-Ratio = 1.13 (Enterprise Value 315.1m / Total Assets 278.2m)
Interest Expense / Debt = 4.11% (Interest Expense 3.72m / Debt 90.5m)
Taxrate = 12.89% (254.0k / 1.97m)
NOPAT = 25.2m (EBIT 28.9m * (1 - 12.89%))
Current Ratio = 1.60 (Total Current Assets 178.4m / Total Current Liabilities 111.6m)
Debt / Equity = 0.82 (Debt 90.5m / totalStockholderEquity, last quarter 110.7m)
Debt / EBITDA = 1.88 (Net Debt 78.2m / EBITDA 41.5m)
Debt / FCF = 2.32 (Net Debt 78.2m / FCF TTM 33.7m)
Total Stockholder Equity = 117.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.18% (Net Income 18.3m / Total Assets 278.2m)
RoE = 15.58% (Net Income TTM 18.3m / Total Stockholder Equity 117.2m)
RoCE = 17.45% (EBIT 28.9m / Capital Employed (Equity 117.2m + L.T.Debt 48.4m))
RoIC = 13.07% (NOPAT 25.2m / Invested Capital 192.7m)
WACC = 10.37% (E(236.9m)/V(327.3m) * Re(12.96%) + D(90.5m)/V(327.3m) * Rd(4.11%) * (1-Tc(0.13)))
Discount Rate = 12.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 8.80%
[DCF Debug] Terminal Value 72.30% ; FCFF base≈23.0m ; Y1≈26.4m ; Y5≈36.7m
Fair Price DCF = 18.07 (EV 427.2m - Net Debt 78.2m = Equity 349.0m / Shares 19.3m; r=10.37% [WACC]; 5y FCF grow 17.14% → 2.90% )
EPS Correlation: 52.56 | EPS CAGR: 19.84% | SUE: -4.0 | # QB: 0
Revenue Correlation: 29.38 | Revenue CAGR: -7.87% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.15 | Chg30d=+0.028 | Revisions Net=+0 | Analysts=3
EPS next Year (2026-12-31): EPS=1.12 | Chg30d=-0.020 | Revisions Net=+1 | Growth EPS=+24.5% | Growth Revenue=+8.7%
P/E Forward = 10.2775
P/S = 0.6823
P/B = 2.117
P/EG = 0.6425
Revenue TTM = 347.2m USD
EBIT TTM = 28.9m USD
EBITDA TTM = 41.5m USD
Long Term Debt = 48.4m USD (from longTermDebt, last quarter)
Short Term Debt = 42.1m USD (from shortTermDebt, last quarter)
Debt = 90.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 78.2m USD (from netDebt column, last quarter)
Enterprise Value = 315.1m USD (236.9m + Debt 90.5m - CCE 12.3m)
Interest Coverage Ratio = 2.69 (Ebit TTM 28.9m / Interest Expense TTM 10.8m)
EV/FCF = 9.34x (Enterprise Value 315.1m / FCF TTM 33.7m)
FCF Yield = 10.71% (FCF TTM 33.7m / Enterprise Value 315.1m)
FCF Margin = 9.72% (FCF TTM 33.7m / Revenue TTM 347.2m)
Net Margin = 5.26% (Net Income TTM 18.3m / Revenue TTM 347.2m)
Gross Margin = 35.62% ((Revenue TTM 347.2m - Cost of Revenue TTM 223.5m) / Revenue TTM)
Gross Margin QoQ = 37.36% (prev 28.64%)
Tobins Q-Ratio = 1.13 (Enterprise Value 315.1m / Total Assets 278.2m)
Interest Expense / Debt = 4.11% (Interest Expense 3.72m / Debt 90.5m)
Taxrate = 12.89% (254.0k / 1.97m)
NOPAT = 25.2m (EBIT 28.9m * (1 - 12.89%))
Current Ratio = 1.60 (Total Current Assets 178.4m / Total Current Liabilities 111.6m)
Debt / Equity = 0.82 (Debt 90.5m / totalStockholderEquity, last quarter 110.7m)
Debt / EBITDA = 1.88 (Net Debt 78.2m / EBITDA 41.5m)
Debt / FCF = 2.32 (Net Debt 78.2m / FCF TTM 33.7m)
Total Stockholder Equity = 117.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.18% (Net Income 18.3m / Total Assets 278.2m)
RoE = 15.58% (Net Income TTM 18.3m / Total Stockholder Equity 117.2m)
RoCE = 17.45% (EBIT 28.9m / Capital Employed (Equity 117.2m + L.T.Debt 48.4m))
RoIC = 13.07% (NOPAT 25.2m / Invested Capital 192.7m)
WACC = 10.37% (E(236.9m)/V(327.3m) * Re(12.96%) + D(90.5m)/V(327.3m) * Rd(4.11%) * (1-Tc(0.13)))
Discount Rate = 12.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 8.80%
[DCF Debug] Terminal Value 72.30% ; FCFF base≈23.0m ; Y1≈26.4m ; Y5≈36.7m
Fair Price DCF = 18.07 (EV 427.2m - Net Debt 78.2m = Equity 349.0m / Shares 19.3m; r=10.37% [WACC]; 5y FCF grow 17.14% → 2.90% )
EPS Correlation: 52.56 | EPS CAGR: 19.84% | SUE: -4.0 | # QB: 0
Revenue Correlation: 29.38 | Revenue CAGR: -7.87% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.15 | Chg30d=+0.028 | Revisions Net=+0 | Analysts=3
EPS next Year (2026-12-31): EPS=1.12 | Chg30d=-0.020 | Revisions Net=+1 | Growth EPS=+24.5% | Growth Revenue=+8.7%